key: cord-104109-k36jya0b authors: Das Jana, Indrani; Kumbhakar, Partha; Banerjee, Saptarshi; Gowda, Chinmayee Chowde; Kedia, Nandita; Kuila, Saikat Kumar; Banerjee, Sushanta; Das, Narayan Chandra; Das, Amit Kumar; Manna, Indranil; Tiwary, Chandra Sekhar; Mondal, Arindam title: Development of a copper-graphene nanocomposite based transparent coating with antiviral activity against influenza virus date: 2020-09-02 journal: bioRxiv DOI: 10.1101/2020.09.02.279737 sha: doc_id: 104109 cord_uid: k36jya0b Respiratory infections by RNA viruses are one of the major burdens upon global health and economy. Viruses like influenza or coronaviruses can be transmitted through respiratory droplets or contaminated surfaces. An effective antiviral coating can decrease the viability of the virus particles in the outside environment significantly, hence reducing their transmission rate. In this work, we have screened a series of nanoparticles and their composites for antiviral activity using Nano Luciferase based highly sensitive influenza A reporter virus. Using this screening system, we have identified copper-graphene (Cu-Gr) nanocomposite shows strong antiviral activity. Extensive material and biological characterization of the nanocomposite suggested a unique metal oxide embedded graphene sheet architecture that can inactivate the virion particles only within 30 minutes of pre-incubation and subsequently interferes with the entry of these virion particles into the host cell. This ultimately results in reduced viral gene expression, replication and production of progeny virus particles, slowing down the overall pace of progression of infection. Using PVA as a capping agent, we have been able to generate a Cu-Gr nanocomposite based highly transparent coating that retains its original antiviral activity in the solid form. The emergence of novel virus strains and the associated outbreaks are becoming a significant threat to 37 mankind (Koven 2020) . The currently ongoing pandemic, caused by the Severe Acute Respiratory 38 Syndrome-Coronavirus 2 (SARS-CoV-2), has brought the majority of the world to a grinding halt, severely 39 impacting health & economy across the nations ( fomites. Thus, the development of low cost and easily scalable antiviral coating materials, which could be 59 widely applied to various surfaces in order to inactivate the virus particles in the environment, may serve 60 as an effective way to reduce the chance of infection and hence to lower the overall speed of transmission. 61 62 Different metal oxides, including Cu and Ag have been explored for their biocidal activity in soluble as 63 well as in insoluble forms (Minoshima et al. 2016 ) . Copper and silver nanoparticles have remarkable 64 sequence from porcine teschovirus. The Nano-Luc-influenza A reporter virus, as a part of its gene 134 expression, synthesizes the PA-2A-NLuc polypeptide, which gets self-cleaved to produce Nano-luciferase. 135 Subsequently, the luciferase activity could be measured as a quantitative estimate of viral gene expression 136 and hence progression of virus replication cycle inside the cells. To test whether the Nano-luciferase activity 137 could actually serve as a proxy to virus replication, we have infected MDCK cells with different amounts 138 of input virus and viral replication/gene expression was monitored using Nano-Glo assay (Promega). As 139 shown in Figure 3A , there is a linear relationship between multiplicity of infection (0.01-0.1) and luciferase 140 light unit measurements (R 2 = 0.9294), where an increase in one log in the input virus amount leads to about 141 50% increase in the luciferase activity or vice versa, measured at 8 hours of post-infection. This data 142 suggests that the Nano-luciferase influenza A reporter virus could serve as an excellent tool to study the 143 antiviral activity of various nanoparticles or their nanocomposites used in this study. 144 In order to test the antiviral activity, we have standardized a "Nano-Luc reporter assay" described in Figure 145 3B. Briefly, Nano-luciferase influenza A reporter viruses were pre-incubated with the 5uM colloidal 146 suspensions of each of the nanoparticles/ composites or with the vehicle control for 30 minutes at room 147 temperature and subsequently used to infect MDCK cells at an MOI of 0.1. Luciferase activity was 148 measured at 8 hours of post infection and plotted as a relative percentage of the vehicle control set ( Figure 149 3C). Prior treatment of the virus stock solution with Cu-Gr composite showed 64% reduction in viral gene 150 expression, while prior treatment with Ag-Gr resulted in 20% reduction. Treatment with other materials 151 shows no significant decrease in luciferase activity. From the correlation of input virus units and the 152 corresponding luciferase activity, as shown in Figure 3A , it can be inferred that prior treatment with Cu-Gr 153 solution resulted in more than 10-fold reductions in the infectious virus population that has been used to 154 infect the MDCK cells. In this context, it should be noted that none of the materials showed substantial 155 cytotoxicity upon Madin-Darby Canine Kidney cells (MDCK) within the concentration range of 0.5 uM -156 5.0 uM as evaluated using MTT assay ( Figure 2) . Hence, the reduction in Nano-luciferase activity as a 157 result of prior exposure to Cu-Gr should be attributed exclusively to the reduction of the infectivity of the 158 Nano-luciferase reporter virus. Henceforth, we focused upon the extensive characterization of the Cu-Gr 159 nanocomposite. 160 161 We have extensively characterized the structural parameters of the synthesized Cu-Gr nanocomposites by 163 optical measurements. Figure 4 A depicts Raman spectra of synthesized Cu-Gr nanocomposite samples at 164 excitation of 532 nm in the range of 200 cm -1 to 3000 cm -1 . With Raman spectroscopy, we are able to cm -1 ) confirms the existence of graphene in the samples synthesized. Generally, D peak originates from 167 defects in the hexagonal sp 2 carbon system while the G peak arises due to the stretching vibration of sp 2 168 carbon pairs in both rings and chains (Ferrari et al. 2006 ). Except, D and G peak, the 2D peak arises at 169 ~2700 cm -1 . The 2D peak originates due to transverse optical (TO) phonons around the K point and is reporter assay in order to identify the optimal time and concentration required for its antiviral activity. The 184 Nano-Luc reporter assay was performed where the influenza A reporter virus was pretreated with the 185 colloidal form of the Cu-Gr nanocomposite for various time periods before using them for infecting MDCK 186 cells. As evidenced from Figure 5A , a sharp decrease (>50%) in the reporter activity was observed as a 187 result of 30 minutes of preincubation with Cu-Gr composite, while longer times of preincubation showed 188 only minor additional reduction. This data suggested that 30 minutes of preincubation with Cu-Gr 189 composite can lead to more than tenfold reduction in input virus titer that ultimately results in ~50% 190 decrease in reporter activity. Subsequently, we tried to identify the optimal concentration of the Cu-Gr 191 composite required for its antiviral activity. Different concentrations of the Cu-Gr composite (50nM, 192 100nM, 500nM, 1µM, 2µM and 5µM, respectively) were used to treat the Nano-Luc influenza A reporter 193 virus for 30 minutes followed by performing Nano-Luc reporter assay with the same. 1µM Cu-Gr nanocomposite shows non-significant decrease in viral titer. This data further substantiates the 207 fact that treatment with 5µM Cu-Gr significantly reduces viral infectivity which results in a decrease in 208 viral gene expression, replication and subsequent production of viral titer ( Figure 5C ). The plaque assay 209 titer data are tabulated in Figure 5D . Each data is a representative of at least three independent experiments, each experiment was performed in 386 triplicate. Graphs are performed in Microsoft Excel and represented as mean standard deviations (n=3). 387 Results were compared by performing two-tailed Student's t test. Significance is defined as p<0.05 and 388 statistical significance is indicated with an asterisk (*). The *p value < 0.05, **p value < 0.01 **p value 389 and ***p < 0.001 were considered statistically significant. Thermal Properties of the Binary-Filler Hybrid Composites with Graphene and 403 Copper Nanoparticles Plasmonic Properties of Copper Nanoparticles Fabricated by Nanosphere 405 Lithography Copper Nanoparticle/Polymer Composites with Antifungal and Bacteriostatic 407 Properties Cu-Ag Bimetallic Nanoparticles on Reduced Graphene Oxide 409 Nanosheets as Peroxidase Mimic for Glucose and Ascorbic Acid Detection Copper Nanoparticles: Aqueous Phase Synthesis and Conductive Films 412 Fabrication at Low Sintering Temperature Situ Raman Spectroscopy of Copper and Copper Oxide Surfaces during Electrochemical Oxygen Evolution Reaction: Identification of CuIII Oxides as Catalytically Active 415 Species Graphene Synthesis: Relationship to Applications Chemistry with Graphene and Graphene Oxide -419 Challenges for Synthetic Chemists Coronaviruses: An Overview of Their Replication Methods in molecular biology Raman Spectrum of Graphene and Graphene Layers Cu and Cu-Based Nanoparticles: Synthesis and Applications in Functionalization of Graphene: Covalent and Non-Covalent 427 Antiviral Activity of Cuprous Oxide Nanoparticles against Hepatitis C Virus 429 in Vitro Application Principles of Virology Harmonic Optical Responses of Single Ag Nanoparticles with Morphology Updating the Accounts: Global Mortality of the 1918-439 1920 'Spanish' Influenza Pandemic Graphene Materials in Antimicrobial Nanomedicine: Current Status 441 and Future Perspectives Anomalous K-Point Phonons in Noble Metal/Graphene Heterostructure 443 Activated by Localized Surface Plasmon Resonance Engla, Journal -2010 -New Engla Nd Journal The Lancet Commission on Pollution and Health Receptor Usage for SARS-CoV-2 and Other Lineage B Betacoronaviruses Viromimetic STING Agonist-Loaded Hollow Polymeric Nanoparticles 452 for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus Preparation, Characterization and Antibacterial Properties of Silver-Modified 455 Low-Viscosity Overlay Medium for Viral Plaque Assays Comparison of the Antiviral Effect of Solid-State Copper and Silver 459 Antimicrobial Mechanisms and Effectiveness of Graphene and Graphene-461 with SARS-CoV-1 A Roadmap for Graphene Can Graphene Take Part in the Fight against COVID-19? Discovery of Direct-Acting Antiviral Agents with a Graphene-Based 472 Fluorescent Nanosensor The Geography and Mortality of the Ion-Based Metal/Graphene Antibacterial Agents Comprising Mono-Ionic 476 and Bi-Ionic Silver and Copper Species One-Step Synthesis of Pt-Decorated Graphene-Carbon Nanotubes for the 478 Electrochemical Sensing of Dopamine, Uric Acid and Ascorbic Acid Strain Specificity in Antimicrobial Activity of Silver and Copper Nanoparticles The Generation of Recombinant Influenza A Viruses 484 Expressing a PB2 Fusion Protein Requires the Conservation of a Packaging Signal Overlapping the Coding and Noncoding Regions at the 5′ End of the PB2 Segment Reviewing the History of Pandemic 487 Influenza: Understanding Patterns of Emergence and Transmission Facile Synthesis and Application of Ag-Chemically Converted Graphene 489 Antibacterial Activities of Solid-State Cuprous Compounds Influenza: The Mother of All Pandemics Antiviral Activity of Graphene Oxide−Silver Nanocomposites_2018.Pdf